PGT-A Testing
Pre-implantation testing for aneuploidy (PGT-A) can be carried out on embryos created during an IVF cycle to test that they have the correct number of chromosomes needed for a successful pregnancy, reducing the risk of miscarriage.
At Care, we offer genetic testing options for your whole reproductive pathway. Helping to build healthy families from the start.
Our whole ethos at Care is to help people have a healthy family. For nearly 20 years, our teams have pioneered the use of Reproductive Genetics techniques, making it possible to test embryos and identify the ones with the correct number of chromosomes, or test for specific genetic diseases before the embryos are implanted.
Pre-implantation testing for aneuploidy (PGT-A) can be carried out on embryos created during an IVF cycle to test that they have the correct number of chromosomes needed for a successful pregnancy, reducing the risk of miscarriage.
Pre-implantation Genetic Testing (PGT-M) allows us to test embryos before transfer if you know you are at high-risk of passing on a specific single gene disorder such as Cystic Fibrosis.
For people with a chromosome structural rearrangement also called a translocation, PGT-SR (Preimplantation Genetic Testing for chromosomal structural rearrangements) can be performed to improve the chance of establishing a healthy pregnancy.
CareUnity is a genetic test which identifies a common cause of recurrent miscarriage and other placental problems. It involves a simple saliva test to look for a specific gene variant that can be found in either parent so medication can be prescribed
We can screen embryos which have already been created to check they are genetically healthy. This is important as, if embryos have a genetic abnormality, such as an incorrect number of chromosomes, there is a higher chance of pregnancy loss, miscarriage, or a baby being born with a genetic condition like Down's Syndrome. Through embryo screening, our embryologists can be sure to only choose embryos which are genetically normal for embryo transfer, therefore increasing the chance of you having a healthy baby and reducing the time to pregnancy.
Embryo screening can be carried out during the IVF treatment process on embryos that have been created in the laboratory. Once your embryos have developed to blastocysts, our embryologists can carefully remove around 5 cells from each embryo in a process called an embryo biopsy. These cells can then be tested for genetic abnormalities.